EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Urinary DNA methylation‐based risk stratification model to triage patients for repeat transurethral resection of bladder tumours

Wei Ouyang, Ran Xu, Hanyu Yao, Shusuan Jiang, Qiang Lu, Cai Lv, Pei Li, Genming Xu, Jianye Liu, Long Wang iD

Clinical and Translational Medicine · 2024-01 · 14 (1)

DOI: 10.1002/ctm2.1549 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Translational Medicine, online erschienen am 22.01.2024. Verfasst von Wei Ouyang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: DNA Methylation, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunan High-Tech Industry Science and Technology Innovation Leading Plan, the National Key R&D Program of China, Bethune Special Research Fund Project of Urological Oncology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationUrinary Bladder NeoplasmsHumansTransurethral Resection of BladderTriageRisk Assessment

Autor:innen und Institutionen

  • Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Department of Urology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medical, Central South University, Changsha, China.
  • Department of Urology, Hunan Provincial People's Hospital, First Affiliated Hospital of Hunan Normal University, Changsha, China.
  • Department of Urology, Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou, China.
  • Yearth Biotechnology Co. Ltd., Changsha, China.

ORCID-Profile: Long Wang

Förderung

  • Hunan High-Tech Industry Science and Technology Innovation Leading Plan
  • the National Key R&D Program of China
  • Bethune Special Research Fund Project of Urological Oncology

Zitieren

APA

Ouyang, W., Xu, R., Yao, H., Jiang, S., Lu, Q., Lv, C., Li, P., Xu, G., Liu, J., & Wang, L. (2024). Urinary DNA methylation‐based risk stratification model to triage patients for repeat transurethral resection of bladder tumours. Clinical and Translational Medicine, 14(1). https://doi.org/10.1002/ctm2.1549

Vancouver

Ouyang W, Xu R, Yao H, Jiang S, Lu Q, Lv C, et al. Urinary DNA methylation‐based risk stratification model to triage patients for repeat transurethral resection of bladder tumours. Clinical and Translational Medicine. 2024;14(1). doi:10.1002/ctm2.1549

BibTeX
@article{Ouyang2024,
  author = {Ouyang, Wei and Xu, Ran and Yao, Hanyu and Jiang, Shusuan and Lu, Qiang and Lv, Cai and Li, Pei and Xu, Genming and Liu, Jianye and Wang, Long},
  title = {Urinary DNA methylation‐based risk stratification model to triage patients for repeat transurethral resection of bladder tumours},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  volume = {14},
  number = {1},
  doi = {10.1002/ctm2.1549}
}
Kostenlos starten →